Back to Archived News
Mannatech Receives Patent for Technology Related to New Product
Tuesday, February 15, 2011
Coppell, TX -- Mannatech, Incorporated (Nasdaq: MTEX), a leading developer and provider of nutritional supplements and skin care products based on Real Food Technology® solutions, announced today the Intellectual Property Office of Singapore has granted the company a patent for technology related to its GI-ProBalance™ product.
Mannatech will celebrate the launch of this revolutionary, synbiotic product to its U.S. market during its annual international conference, MannaFestSM 2011, to be held March 10–12 in Dallas, TX.
The GI-ProBalance product is a pleasant tasting, yogurt-flavored powder packaged in convenient, portable slimsticks. It stimulates immune function, supports proper digestion, as well as GI-tract function, and improves absorption of nutrients.* The probiotic and prebiotic supplement was specifically formulated to work synergistically with Mannatech’s flagship Ambrotose® products. GI-ProBalance slimsticks have already become a successful product for Mannatech’s Asian and Australia/New Zealand markets.
“Having another patented product in our portfolio is great news for the company and our independent sales Associates across the country and around the world,” said Robert A. Sinnott, Ph.D., MNS, co-CEO and chief science officer of Mannatech. “There has been a real drought of innovative, patented products in the nutritional supplement industry over the past few years. This patent validates Mannatech’s tireless efforts to develop quality products based on patented technologies. Innovative products that provide real benefits to people are vital to Mannatech’s growth and the growth of the dietary supplement industry.”
This patent in Singapore strongly validates the quality of GI-ProBalance as it has only been available in that market since late October. Mannatech currently holds 64 patents in 30 countries for its health-related and glyconutrient technologies.
Many of Mannatech’s products are based on Real Food Technology solutions, which provide consumers with products that contain standardized levels of natural and plant-sourced nutrients. Food-sourced ingredients are chosen from those scientifically proven to most benefit the human body.
Individuals interested in Mannatech’s products or in exploring its business opportunity can learn more at mannatech.com.
* These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease.
Mannatech, Incorporated, develops high-quality health, weight and fitness, and skin care products that are based on the solid foundation of nutritional science and development standards. These proprietary products are available through independent sales Associates around the globe including the United States, Canada, South Africa, Australia, New Zealand, Austria, Denmark, Germany, Norway, Sweden, the Netherlands, the United Kingdom, Japan, Taiwan, Singapore, the Republic of Korea and Mexico. For more information, visit mannatech.com.
Please Note: This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. These forward-looking statements generally can be identified by use of phrases or terminology such as “intend” or other similar words or the negative of such terminology. Similarly, descriptions of Mannatech’s objectives, strategies, plans, goals or targets contained herein are also considered forward-looking statements. Mannatech believes this release should be read in conjunction with all of its filings with the United States Securities and Exchange Commission and cautions its readers that these forward-looking statements are subject to certain events, risks, uncertainties, and other factors. Some of these factors include, among others, Mannatech’s inability to attract and retain associates and members, increases in competition, litigation, regulatory changes, and its planned growth into new international markets. Although Mannatech believes that the expectations, statements, and assumptions reflected in these forward-looking statements are reasonable, it cautions readers to always consider all of the risk factors and any other cautionary statements carefully in evaluating each forward-looking statement in this release, as well as those set forth in its latest Annual Report on Form 10-K and Quarterly Report on Form 10-Q, and other filings filed with the United States Securities and Exchange Commission, including its current reports on Form 8-K. All of the forward-looking statements contained herein speak only as of the date of this release.
Back to Archived News